C

Veeva Systems Inc. VEEV

$262.40 $1.420.54% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Veeva Systems Inc. is a cloud software company focused primarily on the global life sciences industry. The company develops industry-specific applications for pharmaceutical, biotechnology, medical device, and related healthcare organizations. Its software supports critical functions including clinical development, regulatory compliance, quality management, medical affairs, commercial operations, and data management. Veeva operates within the enterprise software, cloud computing, and healthcare technology sectors, with revenue primarily generated through subscription-based software services and related professional services.

The company’s principal business lines include the Veeva Commercial Solutions, Veeva Development Cloud, and Veeva Data Cloud product families. Its applications are widely used by large global pharmaceutical companies as well as emerging biotechnology firms. Veeva’s strategic positioning is built around deep specialization in regulated life sciences workflows, high switching costs due to compliance integration, and long-term customer relationships. Founded in 2007 by Peter Gassner and Matt Wallach, Veeva initially focused on customer relationship management applications for pharmaceutical sales teams built on Salesforce infrastructure. The company later expanded into clinical, regulatory, safety, quality, and data solutions, evolving into a broader cloud platform provider for life sciences organizations globally.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Thursday, August 27, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 16 and 20 (est)

Price History

Loading...
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Phone Number
925 452 6500
Address
4280 Hacienda Drive
Pleasanton, CA 94588
Country
Year Founded

Headlines